• Grazoprevir Hydrate: HCV Assay Workflows

  2026-09-04

  Build a reproducible workflow around Grazoprevir hydrate, from NS3/4A biochemical inhibition to genotype-aware cell assays. Practical dosing, controls, and troubleshooting guidance help distinguish true hepatitis C virus replication inhibition from assay artifacts.

• Caspase-3 Fluorometric Assay Kit Workflow

  2026-09-04

  Translate apoptotic signaling into quantitative DEVD-AFC fluorescence with a rapid, plate-based workflow. The assay is especially useful for separating caspase-dependent apoptosis from ferroptosis-associated stress in RSL3 models while guiding troubleshooting, normalization, and orthogonal validation.

• Cell Counting Kit-8 (CCK-8): Reliable Viability Data

  2026-09-03

  This scenario-driven guide explains how Cell Counting Kit-8 (CCK-8), SKU K1018, can improve cell viability, proliferation, and cytotoxicity workflows. It covers assay principles, controls, protocol optimization, data interpretation, and practical product-selection criteria for biomedical laboratories.

• Cyclophosphamide Workflows for Translational Research

  2026-09-03

  Cyclophosphamide supports controlled apoptosis induction in cancer cells, immune-modulation studies, and transplantation-conditioning research. This workflow-focused guide connects formulation, assay design, immune-context modeling, and troubleshooting to improve reproducibility without overstating evidence from unrelated infection models.

• Palmitic acid: Practical Protocol and QC Guide

  2026-09-02

  Palmitic acid (SKU N2456), also called hexadecanoic acid, provides a defined saturated long-chain fatty acid input for lipid metabolism, insulin signaling, inflammation, and palmitoylation workflows. It is water-insoluble and unsuitable for aqueous-only preparation or prolonged solution storage, so solvent compatibility, prompt use, and solid-state storage must be controlled.

• Regorafenib: A Mechanistic Roadmap Beyond Kinases

  2026-09-02

  Regorafenib (BAY 73-4506) is more than a broad-spectrum kinase probe: emerging melanoma research links its activity to RRM2 suppression and ERK/E2F3 signaling. This thought-leadership analysis shows how translational researchers can connect kinase breadth, invasion biology, angiogenesis research, and tumor xenograft models into a more disciplined validation strategy.

• Rimonabant as a CB1 Assay Calibration Tool

  2026-09-01

  Rimonabant (SR141716) is more than a selective CB1 antagonist: it can serve as a pharmacological calibration tool for separating receptor-dependent effects from behavioral and formulation confounders. This article translates withdrawal-model findings into practical decisions for appetite, inflammation, and neurobiology assays.

• Zosuquidar Workflow for P-gp MDR Studies

  2026-09-01

  Build cleaner multidrug-resistance experiments with Zosuquidar (LY335979) 3HCl, from P-glycoprotein function testing to chemotherapy sensitization. This workflow combines concentration-controlled cell assays with transporter, tissue-distribution, and pharmacokinetic logic for more interpretable results.

• Cy3 RNA Labeling Kit: Technical Workflow

  2026-08-31

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus provides an in vitro transcription workflow for producing randomly Cy3-modified RNA probes when fluorescent detection is required. It is suited to research applications such as in situ hybridization and Northern blotting, but the supplied information does not support diagnostic, therapeutic, or clinical use.

• BRD4770: G9a Histone Methyltransferase Inhibitor

  2026-08-31

  BRD4770 is a research-focused G9a histone methyltransferase inhibitor for connecting H3K9 methylation loss with senescence and cancer-cell growth phenotypes. This practical guide emphasizes formulation-aware dosing, time-resolved epigenetic assays, and careful separation of senescence from acute cytotoxicity.

• Pexmetinib (ARRY-614): Reading Time-Resolved Signals

  2026-08-30

  Pexmetinib (ARRY-614) is a dual p38 MAPK and Tie2 inhibitor for studying inflammatory signaling and hematologic disease biology. This article presents a time-resolved framework for distinguishing direct kinase inhibition, altered p38 dephosphorylation, and downstream cytokine suppression in research assays.

• Protein A/G Magnetic Beads: Practical Workflow

  2026-08-29

  Protein A/G Magnetic Beads support Fc-mediated antibody capture for antibody purification, immunoprecipitation, co-IP, and Ch-IP from complex samples. They should be treated as research-use affinity reagents requiring assay-specific optimization, not as diagnostic or medical products or as a substitute for validating antibody and sample compatibility.

• Cy3 NHS ester (non-sulfonated) Guide

  2026-08-28

  Cy3 NHS ester (non-sulfonated), SKU A8100, provides an orange fluorescent NHS-ester reagent for labeling amino groups in proteins, peptides, oligonucleotides, and DNA. It is appropriate for workflows that tolerate DMSO or DMF, but not for strictly aqueous labeling or biomolecules that are highly sensitive to organic co-solvents.

• Bay 11-7821 for NF-κB Inflammation Assays

  2026-08-28

  Bay 11-7821 (BAY 11-7082) provides a practical pharmacological way to test IKK-dependent NF-κB signaling alongside TLR2/TLR4 inflammation models. This workflow-focused guide covers compound handling, monocyte cytokine assays, reporter experiments, apoptosis applications, and troubleshooting for reproducible cancer research.

• Lactate–HMGB1 Signaling in Polymicrobial Sepsis

  2026-08-27

  Yang and colleagues identified lactate as an active regulator of macrophage HMGB1 release rather than only a severity biomarker. The study links lactate uptake to HMGB1 lactylation, acetylation, exosomal secretion, endothelial barrier disruption, and poorer outcomes in polymicrobial sepsis.

8815 records 3/588 page Previous Next 12345 下5页 Last page